Delivery Order SPE2DB22D3019-SPE2DB25FK2YX
Award Date
1/10/25
Potential Completion Date
1/13/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,667.40 and an ultimate completion date of April 21, 2023. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition.
Amerisourcebergen Drug Corp is a subsidiary of...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,811.00 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of June 25, 2024 and was awarded on June 24, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
This federal contract award is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,025.00, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. This award is not associated with a set-aside designation,...
This federal contract award is for the supply of HAVRIX 720 unit/0.5 mL syringes to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $3,143.04, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 24, 2024. The contract is a delivery order with a firm fixed price and an ultimate completion date of April 25, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract is a delivery order with a firm fixed price of $7,735.95 and a completion date of September 11, 2024. Amerisourcebergen has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and...
This federal contract award is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE ML medical products to the Defense Logistics Agency (DLA). The contract, valued at $1,833.70, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition.
Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of 4,564,529,550 units of HAVRIX 1,440 UNIT/ML SYRINGE/ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The Firm Fixed Price contract, valued at $2,758.38, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. The contract has an ultimate completion date of May 8, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,012.50 and is a Firm Fixed Price Delivery Order. It does not have a Set-Aside designation, indicating open competition.
Amerisourcebergen holds a significant...
This federal contract award is for the delivery of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The $4,131.24 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. The contract is not set aside for any specific business type....
This federal contract award is for the delivery of Havrix 1,440 units/mL syringes to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $2,664.93 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has no set-aside designation, indicating open competition.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...